| Mark L. Baum | Chief Executive Officer | FY2025 | |
| Andrew R. Boll | President and Chief Financial Officer | FY2025 | |
| Amir H. Shojaei | Chief Scientific Officer | FY2025 | |
| Francis W. Mullery | President and Chief Executive Officer, ImprimisRx Division | FY2025 | |
| John P. Saharek | Former President and Chief Executive Officer, ImprimisRx Division | FY2025 |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.